Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kestra Medical Technologies (KMTS) EBIT (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed EBIT for 2 consecutive years, with -$31.8 million as the latest value for Q4 2025.

  • On a quarterly basis, EBIT fell 65.95% to -$31.8 million in Q4 2025 year-over-year; TTM through Oct 2025 was -$51.5 million, a 8.25% increase, with the full-year FY2025 number at -$28.4 million, down 43.83% from a year prior.
  • EBIT was -$31.8 million for Q4 2025 at Kestra Medical Technologies, down from -$28.9 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $29.7 million in Q2 2025 to a low of -$31.8 million in Q4 2025.